Full Text View
Tabular View
No Study Results Posted
Related Studies
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
This study is currently recruiting participants.
Study NCT00912041   Information provided by Massachusetts General Hospital
First Received: June 1, 2009   Last Updated: September 17, 2009   History of Changes

June 1, 2009
September 17, 2009
May 2009
September 2015   (final data collection date for primary outcome measure)
The primary endpoint of this Study is to determine the safety of the BrainGate2 Neural Interface System. [ Time Frame: One year post-implant evaluation period ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT00912041 on ClinicalTrials.gov Archive Site
To investigate the feasibility of BrainGate2 and to establish the parameters for a larger clinical study, such as appropriate neural decoding algorithms, sample size, indices of measurement, success criteria, and endpoints. [ Time Frame: Course of the study ] [ Designated as safety issue: No ]
Same as current
 
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

The purpose of this study is to obtain preliminary device safety information and demonstrate proof of principle (feasibility of efficacy) of the ability of people with tetraplegia to control a computer cursor and other assistive devices with their thoughts.

The goal of the BrainGate2 research and development project is to identify the core methods and features for a medical device that could allow people with paralysis to recover a host of abilities that normally rely on the hands.

 
Interventional
Other, Open Label, Single Group Assignment, Safety Study
  • Tetraplegia
  • Spinal Cord Injuries
  • Amyotrophic Lateral Sclerosis
  • Brain Stem Infarctions
  • Locked In Syndrome
Device: Placement of the BrainGate2 sensor into the motor cortex
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
15
December 2015
September 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Clinical diagnosis of spinal cord injury, brainstem stroke, muscular dystrophy, amyotrophic lateral sclerosis or other motor neuron disorders
  • Complete or incomplete tetraplegia (quadriplegia)
  • Must live within a two-hour drive of the Study site
  • (There are additional inclusion criteria)

Exclusion Criteria:

  • Visual impairment such that extended viewing of a computer monitor would be difficult even with ordinary corrective lenses
  • Chronic oral or intravenous steroids or immunosuppressive therapy
  • Other serious disease or disorder that could seriously affect ability to participate in the study
  • (There are additional exclusion criteria)
Both
18 Years to 75 Years
No
Contact: Leigh R Hochberg, M.D., Ph.D. 617-726-4218 clinicaltrials@braingate2.org
United States
 
NCT00912041
Leigh R. Hochberg, M.D., Ph.D., Massachusetts General Hospital
MGH-BG2-TP-001
Massachusetts General Hospital
  • National Center for Medical Rehabilitation Research
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  • National Institute on Deafness and Other Communication Disorders (NIDCD)
Principal Investigator: Leigh R Hochberg, M.D., PH.D. Massachusetts General Hospital
Massachusetts General Hospital
September 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP